Medicus Pharma Ltd. Common Stock
- MDCX
- NASDAQ
- Biotechnology
- Clinical-stage Biotech
- Non-Invasive Therapeutics
$2.92
Today −10.15%Quote Oct 19, 2026, 03:43 PM UTC
−61.90%over the last month
Max drawdown −63.5%From 1-month high −62.0%3 months −81.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$184.5M
Quote Oct 19
Next earnings
Nov 13
Expected, not confirmed
Analyst target
$1.00
−65.8% from here
Floor
$1.44
50.8% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MDCXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
16